ResMed Inc. (CHESS) Company Profile (ASX:RMD)

About ResMed Inc. (CHESS) (ASX:RMD)

ResMed Inc. (CHESS) logoResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Symbol: ASX:RMD
  • CUSIP: N/A
  • Web: www.resmed.com
Average Prices:
  • 50 Day Moving Avg: A$9.60
  • 200 Day Moving Avg: A$9.49
P/E:
  • Trailing P/E Ratio: 41.25
  • P/E Growth: 2.42
Dividend:
  • Dividend Yield: 1.0%
 

Frequently Asked Questions for ResMed Inc. (CHESS) (ASX:RMD)

What is ResMed Inc. (CHESS)'s stock symbol?

ResMed Inc. (CHESS) trades on the ASX under the ticker symbol "RMD."

Who are some of ResMed Inc. (CHESS)'s key competitors?

Who are ResMed Inc. (CHESS)'s key executives?

ResMed Inc. (CHESS)'s management team includes the folowing people:

  • Rob Douglas, President, Chief Operating Officer
  • Michael Farrell, Chief Executive Officer, Director
  • Brett A. Sandercock, Chief Financial Officer
  • Jim Hollingshead Ph.D., President - Americas
  • Anne Reiser, President – Europe & Asia Pacific
  • David Pendarvis, Chief Administrative Officer, Global General Counsel, Company Secretary
  • Agnes Lee, Senior Director - Investor Relations
  • Peter C. Farrell Ph.D., Non-Executive Chairman of the Board
  • Ronald R. Taylor, Lead Independent Director
  • Carol J. Burt, Independent Director


MarketBeat Community Rating for ResMed Inc. (CHESS) (ASX RMD)
Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  66
MarketBeat's community ratings are surveys of what our community members think about ResMed Inc. (CHESS) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ResMed Inc. (CHESS) (ASX:RMD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ResMed Inc. (CHESS) (ASX:RMD)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for ResMed Inc. (CHESS) (ASX:RMD)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for ResMed Inc. (CHESS) (ASX:RMD)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ResMed Inc. (CHESS) (ASX:RMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ResMed Inc. (CHESS) (ASX:RMD)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for ResMed Inc. (CHESS) (ASX:RMD)
Latest Headlines for ResMed Inc. (CHESS) (ASX:RMD)
Source:
DateHeadline
fool.com logo2 healthcare shares to consider if you're new to investing - Motley Fool Australia
www.fool.com.au - September 19 at 7:14 AM
finance.yahoo.com logoETFs with exposure to ResMed, Inc. : August 25, 2017
finance.yahoo.com - August 26 at 8:54 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about ResMed Inc.
finance.yahoo.com - August 13 at 5:54 AM
finance.yahoo.com logoResMed, Inc. :RMD-AU: Earnings Analysis: Q4, 2017 By the Numbers : August 9, 2017
finance.yahoo.com - August 10 at 7:29 AM
finance.yahoo.com logoResMed, Inc. :RMD-AU: Earnings Analysis: 2017 By the Numbers : August 8, 2017
finance.yahoo.com - August 9 at 6:57 AM
fool.com logo3 family-run ASX companies for your investing watchlist - Motley Fool Australia
www.fool.com.au - August 4 at 7:39 AM
fool.com logo5 reasons to buy ResMed Inc (CHESS) shares today - Motley Fool Australia
www.fool.com.au - August 4 at 7:39 AM
finance.yahoo.com logoResMed (RMD) Q4 Earnings Top, 2020 Strategic Goals on Track
finance.yahoo.com - August 2 at 3:57 PM
fool.com logoWant quarterly dividends? Buy these 4 stocks
www.fool.com.au - July 11 at 7:08 AM
fool.com logoWhy the Compumedics Limited share price fell 19% today - Motley Fool Australia
www.fool.com.au - July 8 at 2:05 PM
finance.yahoo.com logoWhy Is ResMed (RMD) Down 3.8% Since the Last Earnings Report?
finance.yahoo.com - May 31 at 12:47 PM
fool.com logoAttention: These 3 healthcare shares are powering the S&P/ASX 200 to new highs - Motley Fool Australia
www.fool.com.au - May 29 at 6:32 PM
fool.com logo2 healthcare shares with dividend yields over 6.5% - Motley Fool Australia
www.fool.com.au - May 29 at 12:59 AM
fool.com logoIs Your Portfolio Diversified? - Motley Fool Australia
www.fool.com.au - May 29 at 12:59 AM
fool.com logoRecord profits: Is Fisher & Paykel Healthcare Corp Ltd still a buy? - Motley Fool Australia
www.fool.com.au - May 23 at 6:58 PM
finance.yahoo.com logoBig Data Yields Big Insights for Treatment of Central Sleep Apnea
finance.yahoo.com - May 22 at 9:19 AM
finance.yahoo.com logoStatement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel
finance.yahoo.com - May 17 at 5:31 AM
finance.yahoo.com logoIntroducing the Softest CPAP Mask from ResMed
finance.yahoo.com - May 16 at 9:31 AM
finance.yahoo.com logoETFs with exposure to ResMed, Inc. : May 11, 2017
finance.yahoo.com - May 11 at 8:02 PM
finance.yahoo.com logoResMed, Inc. :RMD-AU: Earnings Analysis: Q3, 2017 By the Numbers : May 8, 2017
finance.yahoo.com - May 9 at 10:46 AM
finance.yahoo.com logoAcquisitions Help Drive ResMed's Revenue 13% Higher
finance.yahoo.com - May 1 at 10:13 AM
finance.yahoo.com logoResMed (RMD) Beats Q3 Earnings, Misses Sales Estimates
finance.yahoo.com - April 28 at 3:37 PM
fool.com logoWhy ResMed Inc (CHESS) still offers investors big potential
www.fool.com.au - April 27 at 8:00 PM
fool.com logoHere are 3 shares on the S&P/ASX 100 I would buy today - Motley Fool Australia
www.fool.com.au - April 10 at 7:06 PM
fool.com logoHere are 3 quality shares on the S&P/ASX 100 that I would buy today
www.fool.com.au - April 4 at 5:11 AM
fool.com logoASX preview on Thursday: 9 shares you need to watch today - Motley Fool Australia
www.fool.com.au - March 9 at 7:33 PM
fool.com logoASX 200 rebounds on Tuesday: 9 shares you should have been watching
www.fool.com.au - January 24 at 12:55 AM
finance.yahoo.com logoResMed Q2 profit down but revenue up
au.finance.yahoo.com - January 24 at 12:55 AM
finance.yahoo.com logoBlueScope, ResMed news boosts share market
au.finance.yahoo.com - January 24 at 12:55 AM
fool.com logoWhy it’s time to wake up to ResMed Inc.’s (CHESS) potential
www.fool.com.au - January 23 at 7:54 PM
fool.com logoWhy the Australian Dollar is skyrocketing toward US75 cents - Motley Fool Australia
www.fool.com.au - January 13 at 1:18 AM
finance.yahoo.com logoResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders
finance.yahoo.com - January 9 at 8:49 AM
fool.com logoDebt Binge: Is this why the CSL Limited share price is plunging? - Motley Fool Australia
www.fool.com.au - December 12 at 9:27 AM
fool.com logo3 ASX stocks to buy now to get rich later
www.fool.com.au - October 20 at 8:33 AM
fool.com logo4 growth shares I can’t help but love
www.fool.com.au - October 13 at 10:48 AM
fool.com logo4 ASX shares to help you to an early retirement
www.fool.com.au - September 29 at 12:13 PM
fool.com logo3 growth shares I’d buy with $10,000 today
www.fool.com.au - September 16 at 6:50 PM
fool.com logo3 blue-chip shares that won’t let you down
www.fool.com.au - September 10 at 6:17 PM
thestreet.com logoResMed (RMD) Stock Slides, Jefferies Downgrades to 'Underperform'
www.thestreet.com - August 23 at 7:18 PM
finance.yahoo.com logoLook at Medical Product Earnings on Jul 28: BSX, RMD & More
finance.yahoo.com - July 27 at 6:59 AM
fool.com logoThe easy way to start building a $1 million share portfolio in FY 2017
www.fool.com.au - July 20 at 10:00 AM
finance.yahoo.com logoResMed books mixed third-quarter results
au.finance.yahoo.com - April 26 at 8:45 PM
finance.yahoo.com logoResMed Q3 revenue up 7 pct
au.finance.yahoo.com - April 26 at 7:42 PM
finance.yahoo.com logoResMed: Strong Cash Balance, Product Portfolio Drive Growth
finance.yahoo.com - April 8 at 2:50 PM
thestreet.com logoResMed (RMD) Stock Gets 'Underweight' Rating at Barclays
www.thestreet.com - April 7 at 9:17 AM
streetinsider.com logoResMed (RMD) Announces Completion of Inova Labs Acquisition
www.streetinsider.com - February 4 at 2:36 PM
fool.com logoWhy AGL Energy Ltd & Fisher & Paykel Healthcare Corp Ltd could offer growth & income
www.fool.com.au - February 3 at 7:19 PM
rttnews.com logoResMed Inc. (RMD) Jumped To A 6-Week High On Strong Q2 Earnings
www.rttnews.com - January 25 at 1:15 PM
fool.com logoWhy ResMed Inc's Stock Is Up Big Today
www.fool.com - January 22 at 12:17 PM
finance.yahoo.com logoResmed lifts 2Q revenue 7% to $US454.5m
au.finance.yahoo.com - January 21 at 5:50 PM

Social

Social activity is not available for this stock.
This page was last updated on 9/20/2017 by MarketBeat.com Staff